Skip to content

EBITDA margin at other companies

IAR
Integra LifeSciencesIART
-19.5%-30.1pp
MiMedx Group logo
MiMedx GroupMDXG
13.1%-4.5pp
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
3.6%
Solventum logo
SolventumSOLV
31.5%+15.2pp
The Beauty Health Company logo
The Beauty Health CompanySKIN
3.1%+1.7pp
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-63.2%-1.4pp

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Calculated from SANUWAVE Health, Inc.’s reported figures.

Based on trailing twelve months.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s EBITDA margin?
SANUWAVE Health, Inc. (SNWV) reported EBITDA margin of 9.7% in Q1 2026.
How has SANUWAVE Health, Inc.'s EBITDA margin changed year-over-year?
SANUWAVE Health, Inc.'s EBITDA margin decreased by 47.1% year-over-year, from 18.3% to 9.7%.
What is the long-term trend for SANUWAVE Health, Inc.'s EBITDA margin?
Over 3 years (2021 to 2025), SANUWAVE Health, Inc.'s EBITDA margin has grown at a -48.6% compound annual growth rate (CAGR), from -99.2% to 13.4%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.